Which of the following statements best describes the implications of patent issues surrounding the CRISPR-Cas9 technology in the field of medicine?

Patent disputes over CRISPR‑Cas9 can slow the adoption of gene‑editing therapies because companies must first secure licenses, which adds time and cost to research and development. This uncertainty can deter smaller labs from experimenting, limiting scientific progress. It also forces patients to wait longer for new treatments and can raise prices if only a few firms hold the rights. For example, a biotech startup that wants to develop a CRISPR‑based cancer therapy must negotiate a license with the patent holders before it can even begin trials. In short, patent issues create legal and financial hurdles that can delay medical breakthroughs and reduce accessibility.